The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
Norofert, the Romanian producer of organic agricultural inputs and biotechnology provider, has started a share capital increase to raise up to RON 9 million (€1.8 million) following approval from the Financial Supervisory Authority.
Romania recorded the lowest rate of generative artificial intelligence (AI) adoption among young people in the European Union in 2025, according to data released by Eurostat.
Romania's trade deficit decreased by €673 million to €32.7 billion in 2025, representing a 2% improvement compared to 2024, according to data published by the National Institute of Statistics (INS).
Romania's Ministry of Finance has announced the adoption of a Formal Opinion by the Organisation for Economic Co-operation and Development (OECD) Committee on Fiscal Affairs, following the country's evaluation as part of its accession process to the OECD.
Banca de Investiții și Dezvoltare (BID) has signed 18 guarantee agreements with financial intermediaries in Romania.